Status:
COMPLETED
Anterior Chamber Angle Examination in Angle Closure Suspect Patients
Lead Sponsor:
Minia University
Conditions:
Glaucoma
Eligibility:
All Genders
40-70 years
Brief Summary
The aim of this study is to detect PACG suspects using both AS OCT and Scheimpflug imaging.
Detailed Description
Glaucoma is a form of progressive optic neuropathy and is one of the leading causes of preventable blindness worldwide. The average life span is increasing leading to more individuals developing glauc...
Eligibility Criteria
Inclusion
- Hyperopes. 2-Shallow AC. 3-With gonioscopy carried out under dim-light conditions without indentation ,with the eye in primary position there is inability to visualize ≤ 180° of the posterior trabecular meshwork (TM) in the absence of peripheral anterior 4-IOP ≤ 21 as measured by tonometry. 5-Normal visual field on static automated perimetry (SAP) testing. 5-Normal optic nerve head (ONH) appearance on fundus biomicroscopy. 6-Family history of primary angle closure disease.
Exclusion
- 1-Eyes with significant corneal opacity that can impare signal strings of any of the used imaging modalities.
- 2-Eyes wih history of intraocular surgery (e.g. cataract surgery ,retinal detachment surgery).
- 3-Eyes with history of laser procedures (e.g.laser peripheral iridotomy). 4-Eyes with anterior segment pathology as iridocyclitis or angle disgenesis 5. Eyes with history of trauma. 6- Eyes with findings suggestive of 2dry cause of glaucoma (e.g. iris or angle neovascularization, any iris or corneal abnormalities, dilated episcleral vessels ).
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05209204
Start Date
April 1 2019
End Date
January 1 2020
Last Update
January 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minia University hospital
Minya, Egypt